Byooviz
NDC 82667-018 · Harrow Eye, LLC
Generic nameranibizumab-nuna
Dosage formINJECTION, SOLUTION
RouteINTRAVITREAL
Active ingredient(s)RANIBIZUMAB
Strength10 mg/mL
Pharmacologic classVascular Endothelial Growth Factor Inhibitor [EPC], Vascular Endothelial Growth Factor Inhibitors [MoA]
Marketing categoryBLA
Packages
82667-018-05 — 1 VIAL, SINGLE-DOSE in 1 CARTON (82667-018-05) / .05 mL in 1 VIAL, SINGLE-DOSE
Billed under HCPCS
Q5124 — Injection, ranibizumab-nuna, biosimilar, (byooviz), 0.1 mg Medicare Part B payment limit (ASP + 6%): $240.97
Related Codes
Same active ingredient
FDA lists these products with the same active ingredient.
50242-078 — Ranibizumab, 50242-080 — RANIBIZUMAB, 50242-082 — RANIBIZUMAB, 61314-624 — ranibizumab-eqrn, 61314-625 — ranibizumab-eqrn, 64406-019 — ranibizumab-nuna, 70114-440 — ranibizumab-eqrn, 70114-441 — ranibizumab-eqrn, 70710-2172 — ranibizumab-leyk, 70710-2173 — ranibizumab-leyk